During the past decade, Phoenix Pharma (Pty) Ltd conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 5 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 4 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Phoenix Pharma (Pty) Ltd" #1 sponsor was "Pfizer" with 2 trials, followed by "Wits Health Consortium (Pty) Ltd" with 2 trials sponsored, "ApcinteX Ltd" with 1 trials sponsored, "COVID-19 Prevention Network" with 1 trials sponsored and "Catalyst Biosciences" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Phoenix Pharma (Pty) Ltd" #1 collaborator was "Bio Analytical Research Corporation" with 2 trials as a collaborator, "BioVac" with 2 trials as a collaborator, "Biocair" with 2 trials as a collaborator, "Clinical Laboratory Services" with 2 trials as a collaborator and "Dis-Chem Pharmacy" with 2 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Phoenix Pharma (Pty) Ltd" are "Hemophilia A" (2 trials), "Hemophilia A or B" (2 trials), "COVID-19" (1 trials), "HIV Infections" (1 trials) and "Hemophilia B" (1 trials). Many other conditions were trialed in "Phoenix Pharma (Pty) Ltd" in a lesser frequency.

Most popular intervention types in "Phoenix Pharma (Pty) Ltd" are "Biological" (7 trials), "Other" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "PF-06741086" (2 trials), "Placebo" (2 trials), "Ad26.COV2.S" (1 trials), "Booster vaccine" (1 trials) and "Elafibranor" (1 trials). Other intervention names were less common.

The vast majority of trials in "Phoenix Pharma (Pty) Ltd" are 5 trials for "All" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Phoenix Pharma (Pty) Ltd". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Phoenix Pharma (Pty) Ltd, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Phoenix Pharma (Pty) Ltd, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".